additional potency assay data has been sent to the FDA
Like I said before, and phaedrus pointed out- the CRL would stipulate EXACTLY what was required to prove up the potency assay.
That is now submitted
Very promising
Someone needs to ask Si what the FDA turnaround time is on that submission
Woop Woop
Reg
- Forums
- ASX - By Stock
- MSB
- Ann: Half Year Financial Results Presentation
MSB
mesoblast limited
Add to My Watchlist
0.93%
!
$1.63

Ann: Half Year Financial Results Presentation, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.63 |
Change
0.015(0.93%) |
Mkt cap ! $2.082B |
Open | High | Low | Value | Volume |
$1.63 | $1.67 | $1.61 | $6.975M | 4.265M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 707 | $1.63 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 7320 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 707 | 1.630 |
3 | 51200 | 1.625 |
15 | 159486 | 1.620 |
3 | 75310 | 1.615 |
11 | 90509 | 1.610 |
Price($) | Vol. | No. |
---|---|---|
1.635 | 7000 | 1 |
1.640 | 17668 | 3 |
1.645 | 20972 | 3 |
1.650 | 37309 | 4 |
1.655 | 45000 | 3 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online